These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2849024)

  • 21. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M; Dunkel AJ; Thiemann RL; Leibowitz J; Zijlstra M; Jaenisch R
    J Immunol; 1993 Jul; 151(1):266-76. PubMed ID: 8326128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus.
    Altintas A; Cai Z; Pease LR; Rodriguez M
    J Immunol; 1993 Sep; 151(5):2803-12. PubMed ID: 8360494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity in chronic Theiler's virus central nervous system infection.
    Rabinowitz SG; Lipton HL
    J Immunol; 1976 Aug; 117(2):357-63. PubMed ID: 181490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus.
    Peterson JD; Karpus WJ; Clatch RJ; Miller SD
    Eur J Immunol; 1993 Jan; 23(1):46-55. PubMed ID: 8419186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice.
    Welsh CJ; Tonks P; Nash AA; Blakemore WF
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1659-67. PubMed ID: 2953860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.
    Kang BS; Yahikozawa H; Koh CS; Kim BS
    Virology; 2007 Sep; 366(1):185-96. PubMed ID: 17507073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus.
    Rodriguez M; Lucchinetti CF; Clark RJ; Yakash TL; Markowitz H; Lennon VA
    J Immunol; 1988 Feb; 140(3):800-6. PubMed ID: 3339243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.
    Lipton HL; Melvold R
    J Immunol; 1984 Apr; 132(4):1821-5. PubMed ID: 6699403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of Theiler's virus-induced demyelination in nude mice.
    Rosenthal A; Fujinami RS; Lampert PW
    Lab Invest; 1986 May; 54(5):515-22. PubMed ID: 3517486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease.
    Roos RP; Nalefski EA; Nitayaphan S; Variakojis R; Singh KK
    J Neuroimmunol; 1987 Jan; 13(3):305-14. PubMed ID: 3540007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theiler's virus-associated antigens on the surfaces of cultured glial cells.
    Rodriguez M; Siegel LM; Hovanec-Burns D; Bologa L; Graves MC
    Virology; 1988 Oct; 166(2):463-74. PubMed ID: 2845658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Burt RK; Padilla J; Dal Canto MC; Miller SD
    Blood; 1999 Oct; 94(8):2915-22. PubMed ID: 10515897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitus virus.
    Kim BS; Choe YK; Crane MA; Jue CR
    Immunol Lett; 1992 Feb; 31(2):199-205. PubMed ID: 1371268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of irradiation on development of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice.
    Pelka A; Olsberg C; Miller S; Waltenbaugh C; Creighton TM; dal Canto MC; Melvold R
    Cell Immunol; 1993 Dec; 152(2):440-55. PubMed ID: 8258150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice.
    Patick AK; Pease LR; David CS; Rodriguez M
    J Virol; 1990 Nov; 64(11):5570-6. PubMed ID: 2214025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demyelination induced by Theiler's virus: influence of the H-2 haplotype.
    Rodriguez M; David CS
    J Immunol; 1985 Sep; 135(3):2145-8. PubMed ID: 2991380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene.
    Rodriguez M; Kenny JJ; Thiemann RL; Woloschak GE
    Microb Pathog; 1990 Jan; 8(1):23-35. PubMed ID: 2333032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of T cell receptor V beta transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination.
    Rodriguez M; Prayoonwiwat N; Zhou P; David C
    J Neuroimmunol; 1993 Aug; 47(1):95-100. PubMed ID: 8376551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunization with Theiler's virus on the course of demyelinating disease.
    Crane MA; Yauch R; Dal Canto MC; Kim BS
    J Neuroimmunol; 1993 Jun; 45(1-2):67-73. PubMed ID: 8331166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
    Lipton HL
    J Gen Virol; 1980 Jan; 46(1):169-77. PubMed ID: 6243340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.